Now offering custom senolytic compound development and clinical study services - The Senescence Challenge
Cellular senescence – the process by which cells lose their ability to divide and function properly – is a fundamental driver of aging in performance-critical tissues: muscle, brain, and cardiovascular system. These “zombie cells” accumulate, secreting inflammatory factors that erode strength, cognition, and vascular health, and conditions ranging from arthritis to cardiovascular disease.
Revolutionary Screening Technologies
Senolytine™ employs cutting-edge bioinformatics and transcriptome analysis to identify senescence-specific targets. Comparing RNA sequencing data from senescent versus normal cells reveals the survival networks that keep these dysfunctional cells alive – and dragging down muscle, brain, and heart performance.
CRISPR-Cas9 Functional Genomics
Our whole-genome screening approach uses CRISPR-Cas9 technology to systematically knock down genes and identify those whose inactivation selectively eliminates senescent cells while sparing healthy ones. This precision approach has revealed novel senolytic targets beyond the well-known BCL-2 family.
Comprehensive Compound Library
With over 1000 senolytic compounds, Senolytine™ is the world’s most extensive collection of senescence-targeting natural products. Key compounds include:
Fisetin: The Flavonoid Pioneer
This natural flavonoid clears senescent cells in multiple tissue types; clinical trials demonstrate improved physical function in elderly adults – a direct fit for strength products.
Quercetin: The Versatile Senolytic
Combined with dasatinib in clinical studies, quercetin has proven effective in reducing senescent cell burden and improving healthspan markers.
Piperlongumine: The Selective Eliminator
This alkaloid from long pepper shows exceptional selectivity for senescent cells, making it a promising therapeutic candidate.
Clinical Translation and Biomarker Development
Our clinical study services include comprehensive biomarker panels measuring SASP factors, miRNAs, and aging-related transcripts. These tools are essential for evaluating senolytic efficacy in human trials and advancing regulatory approval.
The Future of Healthy Aging
As the first generation of senolytic drugs enters clinical practice, Senolytine™ leads the next wave of natural, safer alternatives that protect muscle, brain, and heart performance.
From Cellular Science to Performance
Cellular senescence sits upstream of what performance-minded consumers want most: maintained muscle and strength, sustained cognitive clarity, and cardiovascular endurance under load. By clearing senescent cells and calming SASP-driven inflammation, Senolytine™ links deep biology to measurable, marketable results across muscle, brain, and sports performance. Partner with Botanicure to bring clinically grounded senolytic ingredients to market in your next product line.